Lombard Medical Technologies' $32 Million Funding to Roll Out Newly Approved Aorfix

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

On the heels of a $32 million funding round, Lombard Medical lands pre-market approval from the FDA for its Aorflex delivery system. Fresh off of a $32 million funding round, Lombard Medical Technologies (LON:LMT) said it won pre-market approval from the FDA for the Aorflex delivery system used with its Aorfix stent graft for treating abdominal aortic aneurysms. The British medical device company said it plans to use the cash to support the U.S. rollout of the Aorfix device.

Help employers find you! Check out all the jobs and post your resume.

Back to news